---
$id: https://graph.org.ai/products/commodity/51151631
$type: Product
source: UNSPSC
code: "51151631"
title: "Dexetimide"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dexetimide

**UNSPSC Code**: 51151631
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C23H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43477QYX3D, chemically known as (rs)-3-(1-benzyl-4-piperidyl)-3-phenyl-2,6-piperidindion but generally known as dexetimide, which bears US NIH Compound Identifier 21847. European Medicines Agency schedules Dexetimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07026MIG. The term DEXETIMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules dexetimide in its Anatomical Therapeutic Chemical (ATC) Classification. DEXETIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexetimide under HS 29333999 and SITC 51574. As of Q4 2014, DEXETIMIDE remains the US FDA Preferred Term for this commodity. Dexetimide bears US NLM identifiers UMLS ID C0011785 and NCI Concept Code C78069. SMILES: O=C1NC(=O)CCC1(C1CCN(CC1)CC1CCCCC1)C1CCCCC1.

